# Phase M1 decision: PRIMARY_EVALUATION_BLOCKED

The primary outcome is **`PRIMARY_EVALUATION_BLOCKED`**. No HMC waveform payload, original scoring outcome, target prediction or clinical metric was read or produced. All clinical values are null. The Phase M0 decision remains `MPI_FEASIBILITY_NOT_ESTABLISHED`.

Recommendation: **BLOCKED — evaluation could not be conducted**. Approximately 7.06 GB persistent capacity fails the estimated 15.7 GB collection plus 2 GB safety reserve. All model identities and header metadata pass; full source integrity, real scoring geometry, predictions and statistical outcomes remain missing. This is not a negative or positive MPI efficacy result. No automatic continuation, training, additional dataset or merge is authorized by this result.

The table answers the assignment's thirty final scientific questions in their original order. All missing outcomes remain explicitly unmeasured.

| Question | Evidence-based answer |
|---|---|
| 1 | Yes: all four exact byte hashes, final-step metadata and architecture authenticated (checkpoint_receipt.json). |
| 2 | Official v1.1 metadata and 151 headers obtained; the complete EEG dataset was not obtained. |
| 3 | Official metadata verified; whole waveform/scoring files and original annotation content not verified. |
| 4 | Unknown eligibility; 151 manifest entries and compatible headers; zero recordings evaluated. |
| 5 | Unique-person/repeat linkage unavailable; recordings retained as clusters; no invented people count. |
| 6 | Yes in all 151 actual headers: literal EEG C4-M1, 256 Hz, uV; full waveform integrity still unavailable. |
| 7 | Generated passband, alias suppression, impulse timing and epoch geometry pass; no real conversion ran. |
| 8 | No predictions were produced or sealed; zero original scoring outcomes opened. |
| 9 | Authenticated source-fit scaler fixed; target normalization fits zero; target application not run. |
| 10 | Not measured: M0 external Macro-F1 is null. |
| 11 | Not measured: M2 external Macro-F1 is null. |
| 12 | Not measured: primary effect is null. |
| 13 | Not measured: both seed effects are null. |
| 14 | Not measured: paired confidence interval is null. |
| 15 | Not evaluated: +0.02 criterion neither passes nor fails. |
| 16 | No stage improvement observed because no clinical outcome was measured. |
| 17 | No stage deterioration observed because no clinical outcome was measured. |
| 18 | N1 recall is unmeasured. |
| 19 | REM recall is unmeasured. |
| 20 | Target class collapse is unmeasured; no severe-failure flag inferred from missing data. |
| 21 | Calibration adequacy is unmeasured; no calibration fitted. |
| 22 | HMC representation stability is unmeasured; historical M0 stability does not answer this question. |
| 23 | HMC prototype informativeness/degeneracy is unmeasured. |
| 24 | F4/M1 is present in all headers but its secondary outcome is unmeasured. |
| 25 | No difference exists to attribute. Matched source arms would isolate their MPI training contrast conditional on fixed seeds and shared architecture/exposure. |
| 26 | Montage/electrode reference, clinical cohort, acquisition hardware/prefilters and provider clipping remain combined. |
| 27 | No new independent transfer support was obtained. |
| 28 | Transfer, clinical stage preservation, multiple-target generalization, label efficiency and clinical prototype semantics remain unsupported. |
| 29 | No second target is justified by this unobserved outcome; do not automatically initiate one. |
| 30 | BLOCKED: stop Phase M1. Preserve M0's failed developmental gate and do not infer method efficacy or start tuning. |
